Dolutegravir-induced acquired sideroblastic anemia in a HIV positive patient: A challenging hematologic complication.

Dolutegravir HIV Naranjo scale acquired sideroblastic anemia adverse drug reaction

Journal

Clinical case reports
ISSN: 2050-0904
Titre abrégé: Clin Case Rep
Pays: England
ID NLM: 101620385

Informations de publication

Date de publication:
Dec 2023
Historique:
received: 14 08 2023
revised: 30 10 2023
accepted: 27 11 2023
medline: 12 12 2023
pubmed: 12 12 2023
entrez: 12 12 2023
Statut: epublish

Résumé

Dolutegravir, the most recent antiretroviral drug with high efficacy, good tolerability, infrequent drug-drug interactions, and a favorable safety profile has not been reported in current literature as a cause of acquired sideroblastic anemia. Here, we present a 35-year-old male patient who was diagnosed with acquired sideroblastic anemia to Dolutegravir therapy.

Identifiants

pubmed: 38084360
doi: 10.1002/ccr3.8301
pii: CCR38301
pmc: PMC10710374
doi:

Types de publication

Case Reports

Langues

eng

Pagination

e8301

Informations de copyright

© 2023 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.

Déclaration de conflit d'intérêts

The authors report no conflicts of interest.

Références

Postgrad Med. 1992 Nov 15;92(7):147-50
pubmed: 1437911
Cold Spring Harb Perspect Med. 2012 Jul;2(7):a006890
pubmed: 22762018
Blood. 2019 Jan 3;133(1):59-69
pubmed: 30401706
Drug Des Devel Ther. 2015 Jul 07;9:3547-55
pubmed: 26185421
Drugs. 2018 Nov;78(16):1741-1750
pubmed: 30406902
HIV Clin Trials. 2014 Sep-Oct;15(5):199-208
pubmed: 25350958
Am J Hematol. 2001 May;67(1):51-3
pubmed: 11279658
PLoS One. 2013;8(1):e52562
pubmed: 23341902
Am J Hematol. 2017 Mar;92(3):297-310
pubmed: 28188970
Am J Hematol. 1988 Jul;28(3):181-3
pubmed: 3407636
J Blood Med. 2020 Sep 25;11:305-318
pubmed: 33061728
Blood. 2009 Jul 30;114(5):937-51
pubmed: 19357394
Genes (Basel). 2022 Aug 30;13(9):
pubmed: 36140729
Clin Pharmacol Ther. 1981 Aug;30(2):239-45
pubmed: 7249508
Acta Haematol. 1967;38(1):1-10
pubmed: 4963348
Haematologica. 2013 Nov;98(11):e138-40
pubmed: 24186315

Auteurs

Kiran Dhonju (K)

Sukraraj Tropical and Infectious Disease Hospital Kathmandu Nepal.

Ashmita Gautam (A)

Tribhuvan University Institute of Medicine Kathmandu Nepal.

Abhinav Dahal (A)

Sukraraj Tropical and Infectious Disease Hospital Kathmandu Nepal.

Niraj Kumar Sharma (NK)

Tribhuvan University Institute of Medicine Kathmandu Nepal.

Divas Adhikari (D)

Bharatpur Hospital Bharatpur Nepal.

Lina Devkota (L)

Sukraraj Tropical and Infectious Disease Hospital Kathmandu Nepal.

Prabhat Adhikari (P)

Center for American Medical Specialists Nepal.

Sampurna Tuladhar (S)

Civil Service Hospital Kathmandu Nepal.

Bishnu Deep Pathak (BD)

Nepalese Army Institute of Health Sciences Kathmandu Nepal.

Sabin Banmala (S)

Nepalese Army Institute of Health Sciences Kathmandu Nepal.

Classifications MeSH